Good Glycemic Control Is Positively Associated with the Levels of Serum Albumin and Postprandial C-Peptide after Long-Term Continuous Subcutaneous Insulin Infusion Treatment in Patients with Type 2 Diabetes

被引:0
|
作者
Choi, Soo-Bong
Noh, Yun-Hee
Lee, Jun-Ho
Lee, Ju-Han
Kim, Seonguk
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2216-PO
引用
收藏
页码:A590 / A590
页数:1
相关论文
共 50 条
  • [31] The effect of short-term continuous intravenous insulin infusion on long-term metabolic control in patients with type 2 diabetes
    Gilewska, Malgorzata
    Pawlowski, Maciej
    Szyllo, Natalia
    Loba, Jerzy
    Czupryniak, Leszek
    CLINICAL DIABETOLOGY, 2015, 4 : 1 - 6
  • [32] Association between Short-Term Postprandial C-Peptide Index Recovery during Hospitalization and Future Glycemic Control in Patients with Type 2 Diabetes
    Enkaku, Asako
    Chujo, Daisuke
    Kamigishi, Miki
    Inagawa, Shinya
    Sakai, Waka
    Matsukoshi, Shinnosuke
    Takikawa, Akiko
    Fujisaka, Shiho
    Tobe, Kazuyuki
    DIABETES, 2023, 72
  • [33] Sepsis uncouples serum C-peptide and insulin levels in critically ill patients with type 2 diabetes mellitus
    Bitker, Laurent
    Cutuli, Salvatore L.
    Cioccari, Luca
    Osawa, Eduardo A.
    Toh, Lisa
    Luethi, Nora
    Young, Helen
    Peck, Leah
    Eastwood, Glenn M.
    Martensson, Johan
    Bellomo, Rinaldo
    CRITICAL CARE AND RESUSCITATION, 2019, 21 (02) : 87 - 95
  • [34] Postprandial serum C-peptide to plasma glucose ratio predicts future insulin therapy in Japanese patients with type 2 diabetes
    Saisho, Yoshifumi
    Kou, Kinsei
    Tanaka, Kumiko
    Abe, Takayuki
    Shimada, Akira
    Kawai, Toshihide
    Itoh, Hiroshi
    ACTA DIABETOLOGICA, 2013, 50 (06) : 987 - 988
  • [35] Postprandial serum C-peptide to plasma glucose ratio predicts future insulin therapy in Japanese patients with type 2 diabetes
    Yoshifumi Saisho
    Kinsei Kou
    Kumiko Tanaka
    Takayuki Abe
    Akira Shimada
    Toshihide Kawai
    Hiroshi Itoh
    Acta Diabetologica, 2013, 50 : 987 - 988
  • [36] Continuous subcutaneous insulin infusion improves glycemic control and quality of life in type 1 diabetes patients with long standing poor glycemic control. A randomized trial
    Devries, JH
    Snoek, FJ
    Kostense, PJ
    Masurel, N
    Heine, RJ
    DIABETES, 2002, 51 : A129 - A129
  • [37] The effect of short-term continuous intravenous insulin infusion on long-term metabolic control in obese patients with type 2 diabetes
    Rutkowska, M.
    Pawlowski, M.
    Loba, J.
    Czupryniak, L.
    DIABETOLOGIA, 2012, 55 : S383 - S383
  • [38] Glycemic control with insulin glargine in patients with type 2 diabetes is safely maintained in long-term exposure
    Karacovsky-Bielesc, G
    Hirtz, R
    DIABETES, 2002, 51 : A293 - A293
  • [39] Effects of Long-term Treatment of Linagliptin on Glycemic Control in Japanese Patients with Type 2 Diabetes
    Kusunoki, Masataka
    Natsume, Yukie
    Tsutsui, Hideyo
    Miyata, Tetsuro
    Tsutsumi, Kazuhiko
    Oshida, Yoshiharu
    INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2018, 14 (08) : 1153 - 1159
  • [40] Long-Term Continuous, Subcutaneous Insulin Infusion Treatment Improved Insulinogenic Index and Proinsulin-to-Insulin Ratio in Longstanding Type 2 Diabetic Patients
    Noh, Yun-Hee
    Lee, Jun-Ho
    Lee, Ju-Han
    Park, Jin-Hee
    Kim, Seonguk
    Choi, Soo-Bong
    DIABETES, 2009, 58 : A61 - A61